Research / FOSL / Fundamental state Inspectable configuration
State dimensions Filing 0000883569-26-000055 General Corporate
Revenue growth 89th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
-4.86% · CORE · VALID
Inventory pressure 69th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
84.85% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
62.38% · CORE · VALID
Operating margin 85th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
1.53% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 14 states History building
Apr 1, 2023 0/6 normalized Level 3 Jul 1, 2023 0/6 normalized Level 3 Sep 30, 2023 0/6 normalized Level 3 Dec 30, 2023 0/8 normalized Level 3 Mar 30, 2024 0/7 normalized Level 3 Jun 29, 2024 0/7 normalized Level 3 Sep 28, 2024 0/7 normalized Level 3 Dec 28, 2024 0/9 normalized Level 3 Apr 5, 2025 6/7 normalized Level 3 Jul 5, 2025 6/7 normalized Level 3 Oct 4, 2025 6/7 normalized Level 3 Jan 3, 2026 6/9 normalized Level 3 Apr 4, 2026 7/7 normalized Level 3 Jul 4, 2026 4/4 normalized Level 3 Period transition
What moved in the state? Growth Decreased
Previous -3.66%
Current -4.86%
Delta -1.20% Inventory Pressure Increased
Previous 69.44%
Current 84.85%
Delta 15.40% Margin Increased
Previous 59.93%
Current 62.38%
Delta 2.44% Profitability Decreased
Previous 5.36%
Current 1.53%
Delta -3.83% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.